(Q43253104)

English

Atorvastatin improves the response to sildenafil in hypercholesterolemic men with erectile dysfunction not initially responsive to sildenafil

scientific article published on 29 October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Atorvastatin improves the response to sildenafil in hypercholesterolemic men with erectile dysfunction not initially responsive to sildenafil (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

hypercholesterolemia

0 references

erectile dysfunction

1 reference

based on heuristic

inferred from title

Mohammad Reza Safarinejad

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

object named as

E Amini

6

0 references

author name string

F Dadkhah

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

M A Asgari

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

S Y Hosseini

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

A Lashay

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

29 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

International Journal of Impotence Research

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

51-60

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

https://scigraph.springernature.com/pub.10.1038/ijir.2009.48

0 references

Sexual dysfunction in the United States: prevalence and predictors

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Prevalence and risk factors for erectile dysfunction in a population-based study in Iran

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

The worldwide prevalence and epidemiology of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Vardenafil rescue rates of sildenafil nonresponders: objective assessment of 327 patients with erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Rechallenge prior sildenafil nonresponders

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Oral sildenafil in the treatment of erectile dysfunction in diabetic men: a randomized double-blind and placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: a double-blind, placebo controlled, randomized study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Safety and efficacy of sildenafil citrate in treating erectile dysfunction in patients with combat-related post-traumatic stress disorder: a double-blind, randomized and placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Salvage of sildenafil failures with bremelanotide: a randomized, double-blind, placebo controlled study.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Effects of statin treatment on serum sex steroids levels and autonomic and erectile function.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Surveillance of cardiovascular risk factors for outpatients in different erectile dysfunction severity

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

A retrospective study of the relationship between biomarkers of atherosclerosis and erectile dysfunction in 988 men.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and pilot trial results

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

HMG-CoA reductase inhibitors: Is the endothelium the main target?

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Heart rate analysis in normal subjects of various age groups

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

21 January 2018

Salvage of sildenafil failures with cabergoline: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

7 January 2021

based on heuristic

inferred from DOI database lookup

Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

7 January 2021

based on heuristic

inferred from DOI database lookup

Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: results from the Krimpen Study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of statin therapy on early return of potency after nerve sparing radical retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of quinapril and atorvastatin on the responsiveness to sildenafil in men with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

7 January 2021

based on heuristic

inferred from DOI database lookup

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

7 January 2021

based on heuristic

inferred from DOI database lookup

HMG CoA Reductase Inhibitors and Impotence

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

7 January 2021

based on heuristic

inferred from DOI database lookup

Comment: HMG-CoA reductase inhibitor-induced impotence

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

7 January 2021

based on heuristic

inferred from DOI database lookup

Erectile dysfunction and statin treatment in high cardiovascular risk patients

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.48

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/IJIR.2009.48

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43253104&oldid=1984891780"